With the UAE health authorities granting regulatory approval to Gilead Sciences to use remdesivir in COVID-19 patients, we take a closer look at its role in the recovery process.
In an exclusive interview with Dubai Eye on One, Frederico Silva, General Manager at Gilead for the Middle East region, explains what remdesivir actually does.
He also explained at what stage a COVID-19 patient should be given the drug.
Silva also touched upon the talks Gilead is having with the UAE Ministry of Health.
Talking about the pricing, he explained how Gilead has come up with two approaches - one for less developed countries and the second for developed nations.
Sheikh Ahmed bin Rashid Al Maktoum laid to rest
UAE, partners renew push for Gaza peace plan
Sheikh Ahmed bin Rashid Al Maktoum passes away; 10-day mourning in Dubai
Funeral prayer for Sheikh Ahmed bin Rashid to be held on Tuesday
UAE detects 377 cases of fake Emiratisation in half-year review
Sheikh Abdullah meets global counterparts at UN
Abu Dhabi to host UN congress on crime and criminal justice
Abu Dhabi strengthens greenhouse gas emissions monitoring
